Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Dec;82(3):435–439. doi: 10.1111/j.1365-2249.1990.tb05467.x

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration.

K Lövgren 1, H Kåberg 1, B Morein 1
PMCID: PMC1535506  PMID: 2265484

Abstract

An experimental influenza virus (A/PR/8/34(H1N1] vaccine was tested and evaluated in mice. The mice were inoculated once or twice intranasally or subcutaneously with 1 or 10 micrograms of iscoms prior to challenge with high dose of live virus. It was demonstrated that two intranasal administrations were as efficient as two s.c. administrations, both routes inducing high levels of antibody and protection against challenge infection. With a one-dose regimen, the s.c. route induced a somewhat higher antibody response than the intranasal route; this might be explained by technical difficulties connected with an intranasal administration.

Full text

PDF
435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  2. Hanatani M., Nishifuji K., Futai M., Tsuchiya T. Solubilization and reconstitution of membrane proteins of Escherichia coli using alkanoyl-N-methylglucamides. J Biochem. 1984 May;95(5):1349–1353. doi: 10.1093/oxfordjournals.jbchem.a134742. [DOI] [PubMed] [Google Scholar]
  3. Hildreth J. E. N-D-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry. Biochem J. 1982 Nov 1;207(2):363–366. doi: 10.1042/bj2070363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jones P. D., Tha Hla R., Morein B., Lovgren K., Ada G. L. Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms). Scand J Immunol. 1988 Jun;27(6):645–652. doi: 10.1111/j.1365-3083.1988.tb02397.x. [DOI] [PubMed] [Google Scholar]
  5. Lövgren K., Lindmark J., Pipkorn R., Morein B. Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier. J Immunol Methods. 1987 Apr 2;98(1):137–143. doi: 10.1016/0022-1759(87)90447-9. [DOI] [PubMed] [Google Scholar]
  6. Lövgren K., Morein B. The requirement of lipids for the formation of immunostimulating complexes (iscoms). Biotechnol Appl Biochem. 1988 Apr;10(2):161–172. [PubMed] [Google Scholar]
  7. Lövgren K. The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand J Immunol. 1988 Feb;27(2):241–245. doi: 10.1111/j.1365-3083.1988.tb02343.x. [DOI] [PubMed] [Google Scholar]
  8. Merz D. C., Scheid A., Choppin P. W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med. 1980 Feb 1;151(2):275–288. doi: 10.1084/jem.151.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Morgan A. J., Finerty S., Lovgren K., Scullion F. T., Morein B. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes. J Gen Virol. 1988 Aug;69(Pt 8):2093–2096. doi: 10.1099/0022-1317-69-8-2093. [DOI] [PubMed] [Google Scholar]
  10. Norrby E., Enders-Ruckle G., Meulen V. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis. 1975 Sep;132(3):262–269. doi: 10.1093/infdis/132.3.262. [DOI] [PubMed] [Google Scholar]
  11. Osterhaus A., Weijer K., UytdeHaag F., Knell P., Jarrett O., Akerblom L., Morein B. Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine. Vaccine. 1989 Apr;7(2):137–141. doi: 10.1016/0264-410x(89)90053-4. [DOI] [PubMed] [Google Scholar]
  12. Osterhaus A., Weijer K., Uytdehaag F., Jarrett O., Sundquist B., Morein B. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J Immunol. 1985 Jul;135(1):591–596. [PubMed] [Google Scholar]
  13. Sundquist B., Lövgren K., Morein B. Influenza virus ISCOMs: antibody response in animals. Vaccine. 1988 Feb;6(1):49–53. doi: 10.1016/0264-410x(88)90014-x. [DOI] [PubMed] [Google Scholar]
  14. Takahashi H., Takeshita T., Morein B., Putney S., Germain R. N., Berzofsky J. A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature. 1990 Apr 26;344(6269):873–875. doi: 10.1038/344873a0. [DOI] [PubMed] [Google Scholar]
  15. Varsanyi T. M., Morein B., Löve A., Norrby E. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J Virol. 1987 Dec;61(12):3896–3901. doi: 10.1128/jvi.61.12.3896-3901.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Vries P., van Binnendijk R. S., van der Marel P., van Wezel A. L., Voorma H. O., Sundquist B., Uytdehaag F. G., Osterhaus A. D. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol. 1988 Mar;69(Pt 3):549–559. doi: 10.1099/0022-1317-69-3-549. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES